rethinkPeptides Search
Menu
Home / Research library
Study breakdown

BPC-157 Counteracts Both NO Blockers and NO Donors' Effects on Stomach and Blood Pressure

RPEP-004311997Sikirić, P; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Konjevoda, P; Perović, D; Jurina, L; Separović, J; Hanzevacki, M; Artuković, B; Bratulić, M; Tisljar, M; Gjurasin, M; Miklić, P; Stancić-Rokotov, D; Slobodnjak, Z; Jelovac, N; Marović, A
Animal StudyPreliminary evidence
The takeaway

BPC-157 counteracted the harmful effects of both NO blocker L-NAME and NO donor L-arginine on stomach mucosa and blood pressure, confirming its NO-modulating role.

Bidirectional NO correction

BPC-157 countered both L-NAME (NO blocker) and L-arginine (NO booster) effects on stomach and blood pressure

What the researchers found

BPC-157 counteracted both L-NAME (NO blocker) and L-arginine (NO donor) effects on gastric mucosa and blood pressure, confirming its role as an NO system modulator.

Why it matters

BPC-157's ability to normalize NO signaling in both directions explains its broad protective effects across many organ systems.

How the study worked

Rats challenged with ethanol-induced gastric lesions and IV blood pressure measurements while receiving L-NAME, L-arginine, or combinations with BPC-157 at two doses.

What this study cannot tell us

Animal study with pharmacological NO manipulation. The doses of L-NAME used create extreme NO blockade not seen physiologically.

How to read the evidence

Moderate animal evidence with clear pharmacological demonstration of dual-direction NO modulation.

When this study was published

Published in 1997, establishing NO modulation as a key BPC-157 mechanism.

The bigger picture

This NO-modulating property is now considered central to BPC-157's mechanism, explaining how it protects the gut, blood vessels, heart, and other tissues.

Questions still open

  • How does BPC-157 sense and respond to NO imbalance in either direction?
  • Is the NO modulation mechanism specific to BPC-157 or shared by other gastric peptides?

Common questions

What is nitric oxide's role?
NO is a critical signaling molecule that dilates blood vessels, protects the stomach lining, and regulates inflammation. Both too much and too little NO causes harm. BPC-157 appears to maintain optimal NO balance.
Why is bidirectional modulation special?
Most drugs either block or boost NO. BPC-157 does neither exclusively — it corrects NO imbalances in whichever direction is needed. This adaptive response is unusual and helps explain its broad therapeutic profile.

Read the original research

The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure.

European journal of pharmacology, 332(1), 23-33

View on PubMed ↗

Citation

Sikirić, P; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Konjevoda, P; Perović, D; Jurina, L; Separović, J; Hanzevacki, M; Artuković, B; Bratulić, M; Tisljar, M; Gjurasin, M; Miklić, P; Stancić-Rokotov, D; Slobodnjak, Z; Jelovac, N; Marović, A. (1997). The influence of a novel pentadecapeptide, BPC 157, on N(G)-nitro-L-arginine methylester and L-arginine effects on stomach mucosa integrity and blood pressure.. European journal of pharmacology, 332(1), 23-33.